Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
54,965,124
-
Total 13F shares
-
16,061,952
-
Share change
-
+2,706,385
-
Total reported value
-
$118,696,041
-
Put/Call ratio
-
229%
-
Price per share
-
$7.39
-
Number of holders
-
72
-
Value change
-
+$17,919,115
-
Number of buys
-
50
-
Number of sells
-
21
Institutional Holders of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) as of Q2 2023
As of 30 Jun 2023,
Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA) was held by
72 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,061,952 shares.
The largest 10 holders included
Blue Water Life Science Advisors, LP, Polar Capital Holdings Plc, VANGUARD GROUP INC, BlackRock Inc., Board of Trustees of The Leland Stanford Junior University, Uniplan Investment Counsel, Inc., MILLENNIUM MANAGEMENT LLC, SVB WEALTH LLC, Granahan Investment Management, LLC, and Parkman Healthcare Partners LLC.
This page lists
72
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.